Biochemical mechanism of pruritus in obstructive jaundice

1. Retained bile acids/salts - Bile duct obstruction stops bile (and bile salts) from reaching the gut, so they reflux into plasma and accumulate in skin and other tissues. This was the classic explanation, and it's why bile-acid-binding resins work - but the correlation with bile acid levels is also imperfect, so it's not the whole story (Sleisenger and Fordtran's Gastrointestinal and Liver Disease, p. 2191).
2. Lysophosphatidic acid (LPA) / autotaxin pathway - Autotaxin, an enzyme that generates LPA, is elevated in cholestatic pruritus and correlates better with itch intensity than bile acids do. LPA is thought to directly activate pruriceptive sensory neurons.
3. Increased endogenous opioidergic tone - Cholestasis raises central opioid peptide activity, which sensitizes central itch pathways. This is why opioid antagonists (naltrexone) relieve itch and why some patients get an opioid-withdrawal-like reaction when starting naltrexone.
4. Bile salts activating pruriceptive receptors - Bile acids can directly stimulate the receptor MRGPRX4 on sensory neurons, triggering the itch signal independent of concentration alone.
5. Serotonergic pathways - central serotonin signaling also modulates the itch, which is the rationale for SSRIs like sertraline.

Can it be treated? Topical vs systemic options

• First-line: Cholestyramine (a bile acid-binding anion exchange resin) - 4 g mixed with water before and after breakfast, can increase to 4x/day. Works by binding bile acids in the gut, interrupting enterohepatic recirculation. Must be dosed away from other drugs since it binds many medications (and fat-soluble vitamins) - Washington Manual of Medical Therapeutics, p. 5756.
• If obstruction is mechanical (stones, stricture, tumor), biliary decompression (ERCP, stenting, surgery) is the definitive treatment and usually the fastest way to resolve pruritus, since it removes the cause rather than just binding a downstream mediator.
• Second-line: Rifampicin (150-300 mg twice daily) - induces hepatic enzymes and alters bile acid metabolism/transport; effective but requires liver function monitoring.
• Naltrexone/opioid antagonists - target the increased central opioid tone; can cause a transient withdrawal-like reaction on initiation.
• Sertraline (SSRI) - used as an adjunct, particularly in primary biliary cholangitis (PBC).
• Ursodeoxycholic acid (UDCA) - alters bile composition and can relieve pruritus in some cholestatic conditions (e.g., biliary atresia, PBC).
• Fibrates (e.g., bezafibrate) - shown in some PBC studies to improve itching substantially (up to ~98% improvement reported in some series - Yamada's Textbook of Gastroenterology).
• Phototherapy (UV-B) - can help refractory cases, sometimes combined with cholestyramine.
• Refractory/severe cases: plasmapheresis, or ultimately liver transplantation if intractable and liver disease is end-stage.

• Antihistamines are commonly tried but are largely ineffective for the itch itself in cholestasis (may help via sedation at night) since histamine is not the primary mediator.
• Newer targeted agents such as odevixibat and other ileal bile acid transporter (IBAT) inhibitors interrupt enterohepatic bile salt circulation and are used in pediatric cholestatic syndromes (e.g., PFIC) with good effect on pruritus - Goldman-Cecil Medicine.